Literature DB >> 25064566

Kotai Antibody Builder: automated high-resolution structural modeling of antibodies.

Kazuo Yamashita1, Kazuyoshi Ikeda1, Karlou Amada1, Shide Liang1, Yuko Tsuchiya1, Haruki Nakamura1, Hiroki Shirai1, Daron M Standley1.   

Abstract

MOTIVATION: Kotai Antibody Builder is a Web service for tertiary structural modeling of antibody variable regions. It consists of three main steps: hybrid template selection by sequence alignment and canonical rules, 3D rendering of alignments and CDR-H3 loop modeling. For the last step, in addition to rule-based heuristics used to build the initial model, a refinement option is available that uses fragment assembly followed by knowledge-based scoring. Using targets from the Second Antibody Modeling Assessment, we demonstrate that Kotai Antibody Builder generates models with an overall accuracy equal to that of the best-performing semi-automated predictors using expert knowledge.
AVAILABILITY AND IMPLEMENTATION: Kotai Antibody Builder is available at http://kotaiab.org CONTACT: standley@ifrec.osaka-u.ac.jp.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Mesh:

Substances:

Year:  2014        PMID: 25064566     DOI: 10.1093/bioinformatics/btu510

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  23 in total

1.  Machine Learning Attempts for Predicting Human Subcutaneous Bioavailability of Monoclonal Antibodies.

Authors:  Hao Lou; Michael J Hageman
Journal:  Pharm Res       Date:  2021-03-12       Impact factor: 4.200

Review 2.  How repertoire data are changing antibody science.

Authors:  Claire Marks; Charlotte M Deane
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

3.  ANTISOMA: A Computational Pipeline for the Reduction of the Aggregation Propensity of Monoclonal Antibodies.

Authors:  Katerina C Nastou; Eleftheria G Karataraki; Nikos C Papandreou; Anna-Isavella G Rerra; Vassiliki P Grimanelli; Ilias Maglogiannis; Stavros J Hamodrakas; Vassiliki A Iconomidou
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Modeling and docking of antibody structures with Rosetta.

Authors:  Brian D Weitzner; Jeliazko R Jeliazkov; Sergey Lyskov; Nicholas Marze; Daisuke Kuroda; Rahel Frick; Jared Adolf-Bryfogle; Naireeta Biswas; Roland L Dunbrack; Jeffrey J Gray
Journal:  Nat Protoc       Date:  2017-01-26       Impact factor: 13.491

5.  Role of Non-local Interactions between CDR Loops in Binding Affinity of MR78 Antibody to Marburg Virus Glycoprotein.

Authors:  Amandeep K Sangha; Jinhui Dong; Lauren Williamson; Takao Hashiguchi; Erica Ollmann Saphire; James E Crowe; Jens Meiler
Journal:  Structure       Date:  2017-11-16       Impact factor: 5.006

6.  LYRA, a webserver for lymphocyte receptor structural modeling.

Authors:  Michael Schantz Klausen; Mads Valdemar Anderson; Martin Closter Jespersen; Morten Nielsen; Paolo Marcatili
Journal:  Nucleic Acids Res       Date:  2015-05-24       Impact factor: 16.971

7.  PIGSPro: prediction of immunoGlobulin structures v2.

Authors:  Rosalba Lepore; Pier P Olimpieri; Mario A Messih; Anna Tramontano
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

8.  ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimation.

Authors:  Jinwoo Leem; James Dunbar; Guy Georges; Jiye Shi; Charlotte M Deane
Journal:  MAbs       Date:  2016-07-08       Impact factor: 5.857

9.  Revisiting antibody modeling assessment for CDR-H3 loop.

Authors:  Hiroshi Nishigami; Narutoshi Kamiya; Haruki Nakamura
Journal:  Protein Eng Des Sel       Date:  2016-11-01       Impact factor: 1.650

10.  SAbPred: a structure-based antibody prediction server.

Authors:  James Dunbar; Konrad Krawczyk; Jinwoo Leem; Claire Marks; Jaroslaw Nowak; Cristian Regep; Guy Georges; Sebastian Kelm; Bojana Popovic; Charlotte M Deane
Journal:  Nucleic Acids Res       Date:  2016-04-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.